|Videos|August 26, 2021

Part 2: IDH1 & IDH2 Inhibitors In Newly Diagnosed AML

Expert continues discussion of IDH1 and IDH2 inhibitors in AML and examines prioritization of IDH1 and IDH2 inhibitors versus venetoclax in newly diagnosed AML.


Latest CME